文献速递银屑病与炎症性皮肤病

Ccr6对咪喹莫特诱导的皮肤病变发展并非必需,尽管影响IL-22产生细胞的表皮归巢

Ccr6 Is Dispensable for the Development of Skin Lesions Induced by Imiquimod despite its Effect on Epidermal Homing of IL-22-Producing Cells.
PubMed 文献 · J Invest Dermatol · 2017-01-20

本研究在咪喹莫特诱导的银屑病样小鼠模型中探究Ccr6的作用,发现Ccr6缺陷小鼠表皮IL-22产生减少(因γδ T细胞募集不足),但并未免受银屑病样病变保护;Ccr6对表皮而非真皮培养细胞的Il22表达关键,且对Ccr6阳性细胞(可能为γδ T细胞亚群)的表皮归巢必需。

要点

  • Ccr6缺陷小鼠在咪喹莫特模型中表皮IL-22减少但皮肤病变未减轻
  • Ccr6对表皮(而非真皮)细胞Il22表达关键
  • Ccr6阳性细胞(可能γδ T细胞亚群)表皮归巢依赖Ccr6

核心结论

  • Ccr6对咪喹莫特诱导的皮肤病变发展并非必需,尽管其影响IL-22产生细胞的表皮归巢。

研究设计与样本

  • 在Ccr6缺陷小鼠上应用咪喹莫特诱导银屑病样模型,并与野生型比较。
  • 利用Ccr6-LacZ敲入小鼠及Rag1-/-小鼠表皮与真皮原代培养,离体刺激评估IL-22产生。

主要发现

  • Ccr6缺陷小鼠表皮IL-22产生减少,源于γδ T细胞募集不足,但未免受银屑病样病变保护。
  • 离体刺激下,Ccr6对表皮培养细胞的Il22表达关键,对真皮培养细胞则不然。
  • Ccr6阳性细胞(可能为γδ T细胞亚群)的表皮归巢需要Ccr6,该亚群是表皮主要潜在IL-22来源。
  • Rag1-/-小鼠表皮与真皮原代培养中,表达Ccr6的先天淋巴样细胞亚群是主要潜在IL-22来源。

临床怎么用

  • 提示靶向Ccr6可能不足以阻断咪喹莫特诱导的银屑病样皮肤炎症。
  • 评估IL-22来源时需区分表皮与真皮微环境的不同调控机制。

局限性

  • 研究仅基于咪喹莫特诱导的小鼠模型,结论外推至人类银屑病需谨慎。
  • 未明确Ccr6非依赖的病变发展机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Expression of the chemokine receptor Ccr6 is shared by most IL-22-producing cells, and Ccr6-deficient mice showed decreased IL-22 production and skin inflammation upon IL-23 intradermal injections. To determine whether this observation might be extended to another psoriasis model, we applied imiquimod on Ccr6-deficient mice. Although epidermal IL-22 production was decreased because of a deficient recruitment of γδ T cells in these mice, they were not protected against psoriatic lesions. When primary epidermis or dermis tissue culture cells from nontreated mice were stimulated ex vivo with IL-1α/IL-2/IL-23, we observed that Ccr6 is crucial for Il22 expression from epidermal but not dermal cultures. Taking advantage of Ccr6-LacZ-knock-in mice, we showed that Ccr6 is necessary for the homing of Ccr6-positive cells, probably a γδ T-cell subset, which represents the main potential IL-22 source in the epidermis. Similar results were observed in Rag1-/- epidermis and dermis primary cultures, in which a subset of innate lymphoid cells expressing Ccr6 represents the main potential source of IL-22. Taken together, our data show that Ccr6 is not required for the development of skin lesions induced by imiquimod despite its effect on epidermal homing of IL-22-producing cells.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Cochez PM, Michiels C, Hendrickx E, et al. Ccr6 Is Dispensable for the Development of Skin Lesions Induced by Imiquimod despite its Effect on Epidermal Homing of IL-22-Producing Cells. J Invest Dermatol. 2017. PMID: 28115058. doi:10.1016/j.jid.2016.12.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。